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Background: Monitoring of biomarkers, like urea, prostate-specific antigen (PSA), and 
osteopontin, is very important because they are related to kidney disease, prostate cancer, and 
ovarian cancer, respectively. It is well known that reverse iontophoresis can enhance transdermal 
extraction of small molecules, and even large molecules if reverse iontophoresis is used together 
with electroporation. Electroporation is the use of a high-voltage electrical pulse to create nano-
channels within the stratum corneum, temporarily and reversibly. Reverse iontophoresis is the 
use of a small current to facilitate both charged and uncharged molecule transportation across 
the skin. The objectives of this in vitro study were to determine whether PSA and osteopontin 
are extractable transdermally and noninvasively and whether urea, PSA, and osteopontin can 
be extracted simultaneously by electroporation and reverse iontophoresis.
Methods: All in vitro experiments were conducted using a diffusion cell assembled with the 
  stratum corneum of porcine skin. Three different symmetrical biphasic direct currents (SBdc), five 
various electroporations, and a combination of the two techniques were applied to the diffusion cell 
via Ag/AgCl electrodes. The three different SBdc had the same current density of 0.3 mA/cm2, but 
different phase durations of 0 (ie, no current, control group), 30, and 180   seconds. The five different 
electroporations had the same pulse width of 1 msec and number of pulses per second of 10, but 
different electric field strengths of 0 (ie, no voltage, control group), 74, 148, 296, and 592 V/cm. 
Before and after each extraction experiment, skin impedance was measured at 20 Hz.
Results: It was found that urea could be extracted transdermally using reverse iontophoresis 
alone, and further enhancement of extraction could be achieved by combined use of electropo-
ration and reverse iontophoresis. Conversely, PSA and osteopontin were found to be extracted 
transdermally only by use of reverse iontophoresis and electroporation with a high electrical 
field strength (.296 V/cm). After application of reverse iontophoresis, electroporation, or a 
combination of the two techniques, a reduction in skin impedance was observed.
Conclusion: Simultaneous transdermal extraction of urea, PSA, and osteopontin is possible only 
for the condition of applying reverse iontophoresis in conjunction with high electroporation.
Keywords: electroporation, reverse iontophoresis, nanochannels, noninvasive, urea, prostate-
specific antigen, osteopontin
Background
Prostate cancer,1 ovarian cancer, and kidney disease are global health problems. Prostate 
cancer holds the seventh position of leading causes of cancer deaths in Taiwan.2,3 About 
50% of prostate cancer is at an advanced stage by the time the disease is detected. 
In Taiwan, ovarian cancer holds the second position among gynecological reproduc-
tive cancers, just behind cervical cancer.4 Kidney disease held the eighth position of 
  leading causes of death in Taiwan in 2008,4 and the prevalence of dialysis in Taiwan 
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holds first place worldwide. Obviously, these statistics were 
the motivation for this study.
The biomarkers for prostate cancer, ovarian cancer, 
and kidney disease are prostate-specific antigen (PSA),5 
osteopontin,6,7 and urea, respectively. A normal range for 
blood PSA level is generally 0.3–2.5 ng/dL for men under 
50 years of age, while men (under 50 years) with prostate 
cancer usually have a blood PSA level ranging from 0.4 to 
163 ng/dL.8 In contrast, a normal blood osteopontin level for 
women is about 178 ng/mL. However, women with ovarian 
cancer usually have a blood osteopontin level of 486.5 ng/mL.9 
Also, the normal range for blood urea in adults is generally 
10–20 mg/dL. Regular checking of these biomarkers can 
reduce the incidence and mortality rate for people who are at 
high risk of these diseases. However, current clinical methods 
to monitor these biomarkers involve blood sampling, the pain 
and inconvenience of which provides considerable impetus 
for the development of noninvasive methods for frequent 
monitoring of blood PSA, osteopontin, and urea.
Skin provides a unique gateway for noninvasive   monitoring. 
Recently, reverse iontophoresis techniques have been used 
for patient monitoring10,11 and noninvasive diagnosis.12,13 
  Electroporation techniques have also been used for noninva-
sive metabolite extraction,14 achieved by formation of transient 
nanometer-wide aqueous pores across the skin. Because of 
aqueous pore formation, it would be expected that electropora-
tion can assist reverse iontophoresis for transdermal extraction 
of molecules with bigger size and in a shorter time.
Reverse iontophoresis refers to the passage of a low 
level of current through the skin to promote extraction of 
both charged and neutral molecules.15 However, transdermal 
extraction enhanced by reverse iontophoresis is limited 
to molecules having a molecular weight of 20 kDa or 
less.16 Therefore, it can be expected that urea (molecular 
weight 60 Da) can be extracted by reverse iontophoresis. 
However, the molecular weights of PSA (34 kDa) and 
osteopontin (33 kDa) are much larger than 20 kDa, so 
reverse iontophoresis alone may not be able to facilitate 
transdermal extraction.   Electroporation involves the creation 
of transient nanometer-wide aqueous pores across lipid 
bilayer membranes by applying a short, high voltage pulse.17 
Research has suggested that electroporation might enhance 
skin permeability of molecules with a molecular weight 
of at least 40 kDa.18,19 Therefore, combined use of reverse 
iontophoresis and electroporation for transdermal extraction 
of PSA, osteopontin, and urea may be possible.
The aims of this study were to determine whether 
PSA and osteopontin are extractable transdermally and 
  noninvasively, and whether urea, PSA, and osteopontin can 
be extracted simultaneously by electroporation and reverse 
iontophoresis.
Materials and methods
Reagents and solutions
All reagents used in this study are commercially available and 
were used without further purification. Phosphate-buffered 
saline and urea (molecular weight 60 Da) were purchased from 
Sigma Chemical Company (St Louis, MO). PSA (molecular 
weight 34 kDa) was purchased from Enzo Life Sciences 
(Farmingdale, NY). Osteopontin (molecular weight 33 kDa) 
was purchased from Acris Antibodies (San Diego, CA). The urea 
assay kit was purchased from BioVision (Mountain View, CA). 
A PSA BioAssayTM enzyme-linked immunosorbent assay kit 
was purchased from United States Biological (Swampscott, 
MA). An osteopontin enzyme immunometric assay kit was 
purchased from Assay Designs (Ann Arbor, MI). Deionized 
water (resistivity $18 MΩcm) was used for preparation of all 
solutions,. The deionized water was purified by a Millipore 
Milli-Q UFplus System (Bedford, MA).
Equipment
For all in vitro extraction experiments, a diffusion cell was 
used and was the same as previously described (Figure 1).20 
Homemade electroporation and reverse iontophoresis devices 
were used to apply the necessary electric pulse and current, 
respectively, to the diffusion cell via silver-silver chloride 
(Ag/AgCl) electrodes. The electroporation device has an 
accuracy of ±0.01 msec on timing and ±0.1 V on delivering 
voltage, whereas the reverse iontophoresis device has an 
accuracy of ±0.01 msec on timing and ±0.01 µA on deliv-
ering current. For Ag/AgCl electrode fabrication, a silver 
wire (0.1 cm diameter, 2.5 cm length, 99.99% pure; Aldrich 
Chemical Company Inc, Milwaukee, WI) was chloridized 
by immersion in 100 mM HCl solution, with the platinum 
electrode as the cathode for 1.5 hours at an applied constant 
current of 0.314 mA. All colorimetric analysis was performed 
using a Bio-Rad 680 microplate reader (Bio-Rad, Hemel 
Hempstead, UK). An impedance analyzer (Precision Imped-
ance Analyzer WK6420C, Wayne Kerr Electronics Ltd, UK) 
was used for skin impedance measurements.
In vitro studies
All in vitro experiments were performed using a diffusion 
cell, in two halves, comprising two upper electrode chambers 
and a lower chamber. Porcine ear skin (0.25 mm), obtained 
from Padgett Dermatome (Integra LifeSciences Corporation, 
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Plainsboro, NJ) was used to separate the two upper electrode 
chambers from the lower chamber. Phosphate-buffered saline 
(100 mM, pH 7.0) was used to fill the two upper electrode 
chambers (300 µL each) and the lower chamber (about 25 mL). 
However, the lower chamber also contained 5 mM urea, 7 ng/
mL PSA, and 147 ng/mL osteopontin. Solution in the lower 
chamber acts as the interstitial fluid under the skin at normal 
physiological levels. Each electrode chamber contained a Ag/
AgCl electrode, with each electrode placed approximately 
0.1 cm above the porcine skin. The surface area of the porcine 
skin exposed to the electrode in each chamber was 0.2 cm2 and 
the electrode chambers were 1.1 cm apart. Different modes 
of electroporation and reverse iontophoresis (Table 1 and 
Figure 2) were applied to the diffusion cell via the Ag/AgCl 
electrodes. The entire contents of the electrode chambers were 
removed at the end of each experiment to determine the amount 
of urea, PSA, and osteopontin extracted.
Immediately before and after each extraction experiment 
(see Figure 2), pre-experimental skin impedance (Zbefore) and 
post-experimental skin impedance (Zafter) were measured at 
20 Hz via the Ag/AgCl electrodes using an impedance analyzer 
in order to compute the ratio of pre-experimental to post-
experimental skin impedance (ie, Zbefore/Zafter). The amplitude of 
the perturbing wave was limited to 200 mV . In all cases, three 
separate sets of measurements were made in succession in order 
to check for reliability of   measurements. Pictures of the skin 
surface were also captured by a microscope immediately before 
and after each extraction experiment, in order to investigate for 
any changes in the skin surface after the experiment.
Determination of extracted urea,  
PSA, and osteopontin
A colorimetric clinical chemistry assay method adapted for 
use with the Bio-Rad microplate reader was used to quantify 
Electroporation device Reverse iontophoresis device
Ag/AgCl electrode
300 µL PBS (100 mM, pH 7.0)
25 mL PBS (100 mM,
pH 7.0) with 5 mM
urea, 7 ng/mL PSA
and 147 ng/mL OPN
Silicon gaskets
Lower
chamber
Acryl
Porcine ear skin
(0.25 mm thick)
Electrode chamber
Figure 1 Diffusion cell for in vitro extraction experiments. The function of the silicon gasket is to prevent leakage of liquid between the electrode chambers and to ensure 
that current only passes through the skin without any current leakage between electrode chambers. 
This figure is modified from Lee et al.21
Abbreviations: PBS, phosphate-buffered saline; PSA, prostate-specific antigen; OPN, osteopontin.
Table 1 Experimental protocol to show various combinations of electroporation and reverse iontophoresis for in vitro extraction 
experiments
Urea, PSA, and osteopontin 
extraction
Electroporation parameters
Pulse width = 1 msec 
Number of pulses per second = 10
No voltageb 74 V/cm 148 V/cm 296 V/cm 592 V/cm
Reverse iontophoresis parameters 
Symmetrical biphasic dc (0.3 mA/cm2)
No currenta
30 second phase duration
180 second phase duration
Notes: aNo current: 0 second phase duration acting as control group; bno voltage: 0 V/cm acting as control group.
Abbreviation: PSA, prostate-specific antigen.
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the amount of urea, PSA, and osteopontin, using their 
corresponding assay kits and assay procedures mentioned in 
the user manuals. For the urea assay, 50 µL of the extracted 
solution or standard solution was used. Incubation was at 37°C 
for 60 minutes in a dark environment, and the optical density 
of the mixed solutions (standard/extracted solutions and 
quantifying reagents) was read at 570 nm. For the PSA assay, 
50 µL of the extracted solution or standard solution was used. 
Incubation was at 37°C for 30 minutes, and the optical density 
of the mixed solutions was read at 450 nm. For the osteopontin 
assay, 100 µL of the extracted solution or standard solution was 
used. Incubation was at 25°C for 30 minutes on a plate shaker 
at about 500 rpm. The optical density of the mixed solutions 
was read at 405 nm. Excellent linear relationships between 
urea (r2 . 0.95), PSA (r2 . 0.92), and osteopontin (r2 . 0.90) 
concentrations and their relative absorbance were found. This 
allowed the urea, PSA, and osteopontin concentrations to be 
calculated simply by their linear regressions.
Statistical analysis
One-way analysis of variance was used to determine 
whether there were significant differences between reverse 
  iontophoresis parameters within an electroporation param-
eter, and between electroporation parameters within a reverse 
iontophoresis parameter for urea, PSA, and osteopontin 
extraction. One-way analysis of variance was also used to 
determine whether there were significant differences between 
reverse iontophoresis parameters and the electroporation 
parameter for the test parameters of Zbefore/Zafter. Post hoc 
comparisons were made with the least significant difference 
test. All statistical analyses were carried out using SPSS 
software (SPSS Inc, Chicago, IL), with the level of statistical 
significance set at 0.05.
Results
Our in vitro studies of transdermal and noninvasive extraction 
of urea, PSA, and osteopontin by different combinations of 
electroporation and reverse iontophoresis are summarized in 
Figures 3–5. From Figure 3, it can be seen that reverse ion-
tophoresis, with or without combined use of   electroporation, 
can generally facilitate more transdermal urea extraction as 
compared with the controls (no reverse iontophoresis and 
electroporation applications, ie, diffusion only) as well as the 
groups receiving electroporation alone. On the other hand, 
Beginning of 
experiment 
Middle of 
experiment 
End of 
experiment 
1.  Impedance measurement
−3 trials of measurement at  
20 Hz
2. Application of electroporation 
(60 s)
−Polarity reversing every 10 s 
3. Application of electroporation 
(60 s)
−Polarity reversing every 10 s 
3 trials of measurement 
1. Impedance measurement
at 20 Hz
2. Sample collection
Application of reverse 
iontophoresis (18 min)
Symmetrical biphasic dc with the 
phase duration of 30 s and 180 s 
Application of reverse 
iontophoresis (18 min)
Symmetrical biphasic dc with the 
phase duration of 30 s and 180 s 
Figure 2 Experimental protocol showing the time sequence for skin impedance measurements, application of electroporation and reverse iontophoresis, and sample collection. 
Note: Each in vitro extraction experiment took 38 minutes.
Abbreviations: min, minutes; s, seconds.
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urea extraction by reverse iontophoresis, having a phase 
duration of 180 seconds, was generally observed to be higher 
than that of 30 seconds, but no significant difference was 
found. Further, in the same reverse iontophoresis setting, it 
was found that urea extraction generally could be enhanced 
by an increase in the electrical field strength of electropora-
tion. Moreover, in the same reverse iontophoresis setting 
(phase duration 30 seconds or 180 seconds), urea extraction 
by electroporation at 592 V/cm was found to be significantly 
higher (P , 0.001) than that by electroporation at no voltage, 
and 74 and 148 V/cm. Also, electroporation at 296 V/cm was 
found to enhance (P , 0.001) urea extraction significantly 
more than electroporation at no voltage, and 74 and 148 V/
cm. Electroporation at 148 V/cm was also found to increase 
urea extraction significantly (P , 0.001) compared with 
electroporation at no voltage.
Figure 4 shows transdermal extraction of PSA by 
different combinations of electroporation and reverse 
iontophoresis. It was observed that diffusion (no reverse 
iontophoresis or electroporation) and reverse iontophoresis 
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Figure 3 In vitro studies (n = 3 for each bar) of the transdermal and noninvasive extraction of urea by electroporation, reverse iontophoresis, and a combination of these 
methods. For the electroporation setting, they all have the same pulse width of 1 msec and number of pulses per second of 10. The legend shows the reverse iontophoresis 
setting, which is a symmetrical biphasic dc with a current density of 0.3 mA/cm2. 
Notes: Results are expressed as the mean ± standard deviation. **P , 0.001.
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Figure 4 In vitro studies (n = 3 for each bar) of transdermal and noninvasive extraction of PSA by various electroporation, reverse iontophoresis, and a combination of 
the two methods. For the electroporation setting, they all have the same pulse width of 1 msec and number of pulses per second of 10. The legend shows the reverse 
iontophoresis setting, which is a symmetrical biphasic dc with a current density of 0.3 mA/cm2.
Notes: Results are expressed as mean ± standard deviation.**P , 0.001, *P , 0.05.
Abbreviation: PSA, prostate-specific antigen.
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alone   cannot facilitate transdermal PSA extraction. On the 
other hand, electroporation alone with high voltage densities 
(296 and 592 V/cm) was found to induce extremely small 
PSA transdermal extraction. Importantly, it was found that 
combining high electroporation (either 296 or 592 V/cm) 
with reverse iontophoresis (phase duration 30 seconds 
or 180 seconds) could achieve more PSA extraction than 
electroporation alone with high voltage densities of 296 
and 592 V/cm. Moreover, with application of reverse ion-
tophoresis and under the same reverse iontophoresis setting 
(phase duration 30 seconds or 180 seconds), PSA extraction 
by electroporation at 592 V/cm was found to be significantly 
higher than that by electroporation at no voltage, and 74 
and 148 V/cm (P , 0.001) and electroporation at 296 V/cm 
(P , 0.05). Also, with application of reverse iontophoresis 
and under the same reverse iontophoresis setting (phase 
duration 30 seconds or 180 seconds), PSA extraction by 
electroporation at 296 V/cm was found to be significantly 
(P , 0.001) higher than that by electroporation at no voltage, 
and 74 and 148 V/cm.
Figure 5 shows transdermal extraction of osteopontin 
by various combinations of electroporation and reverse 
  iontophoresis. It was observed that diffusion (no reverse 
iontophoresis or electroporation), electroporation, or 
reverse iontophoresis alone cannot facilitate osteopontin 
transdermal extraction. On the other hand, it was found that 
combining higher electroporation at either 296 or 592 V/cm 
with reverse iontophoresis (phase duration 30 or 180 seconds) 
can facilitate transdermal extraction of osteopontin.   Moreover, 
with application of reverse iontophoresis, osteopontin extrac-
tion by electroporation at no voltage, and 74 and 148 V/cm 
was found to be significantly smaller (P , 0.001 for all cases) 
than that by electroporation at 296 and 592 V/cm.
Figure 6 shows the effect of electroporation and 
reverse iontophoresis on the ratio of pre-experimental 
to post-experimental skin impedance. It was observed 
that the diffusion process (ie, no reverse iontophoresis 
or electroporation) results in a small reduction of 
skin impedance while electroporation alone, reverse 
iontophoresis alone, or combinations of electroporation 
and reverse iontophoresis cause a huge reduction of skin 
impedance as compared with the diffusion process. On the 
other hand, reduction of post-experimental skin impedance 
caused by reverse iontophoresis having a phase duration of 
180 seconds was generally observed to be similar to that 
of 30 seconds, and no significant difference was found. 
Further, under the same reverse iontophoresis setting, 
it was found that the increase of electrical field strength 
of electroporation could generally further decrease post-
experimental skin impedance.
Figure 7 shows the ratio of pre-experimental skin 
impedance to post-experimental skin impedance at vari-
ous times after application of electroporation (electric field 
strength = 592 V/cm; pulse width = 1 msec; number of pulses 
per second = 10) and reverse iontophoresis (symmetrical 
biphasic dc; current density = 0.3 mA/cm2; phase dura-
tion = 180 seconds). No significant changes were found, but 
a steady decrease in the ratio with time was observed.
Figure 8 shows the pictures of the skin surface before 
and after each extraction experiment. No significant changes 
at the skin surface were observed after application of elec-
troporation and reverse iontophoresis.
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Figure 5 In vitro studies (n = 3 for each bar) of transdermal and noninvasive extraction of osteopontin by various electroporation, reverse iontophoresis, and a combination 
of the two methods. For the electroporation setting, they all have the same pulse width of 1 msec and the number of pulses per second of 10. The legend shows the reverse 
iontophoresis setting, which is a symmetrical biphasic dc with a current density of 0.3 mA/cm2.
Notes: Results are expressed as the mean ± standard deviation. **P , 0.001.
Abbreviation: OPN, osteopontin.
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Discussion
In this study, all transdermal extraction experiments were 
conducted using a diffusion cell in order to establish an in 
vitro model, which has the advantages of simplicity, easy 
handling, inexpensiveness, and an ability to simulate disease 
conditions. Although an in vivo model is a good choice for 
transdermal extraction experiments, it is relatively expen-
sive, and it is quite difficult to create the necessary disease 
  conditions. In this study, a normal physiological in vitro 
model (5 mM urea, 7 ng/mL PSA, and 147 ng/mL osteopon-
tin) was established in order to simulate a healthy person with 
normal blood urea, PSA, and osteopontin levels. As shown 
in Figures 3–5, the results for urea, PSA, and osteopontin 
extraction, respectively, show that the maximum detected 
values were much less than the normal physiological values 
for these biomarkers. This is because all these biomarkers 
in interstitial fluid, rather than in blood, have been extracted 
and the concentration of these biomarkers in the interstitial 
fluid is relatively lower than that in blood. Moreover, the skin 
provides a barrier to reduce the extraction of these biomarkers 
further. Our results are in agreement with others who also 
reported that the maximum detected value of glucose is much 
less than the normal physiological value in blood.22
Urea is a negatively charged molecule with a small molec-
ular weight of approximately 60 Da. As expected, reverse 
iontophoresis alone can enhance transdermal extraction of 
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Figure 6 Effect of electroporation and reverse iontophoresis on the ratio of pre-experimental to post-experimental skin impedance (ie, Zbefore/Zafter). All skin impedance 
measurements were conducted at 20 Hz. For the electroporation setting, they all have the same pulse width of 1 msec and the number of pulses per second of 10. The legend 
shows the reverse iontophoresis setting, which is a symmetrical biphasic dc with the current density of 0.3 mA/cm2.
Notes: Results (n = 3) are expressed as the mean ± standard deviation. **P , 0.001; *P , 0.05, respectively.
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Figure 7 Effect of electroporation (electric field strength = 592 V/cm; pulse width = 1 msec; number of pulses per second = 10) and reverse iontophoresis (symmetrical 
biphasic dc; current density = 0.3 mA/cm2; phase duration = 180 seconds) on the ratio of pre-experimental to post-experimental skin impedance at various times after the 
extraction experiment.
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urea through the process of electromigration, and further 
urea extraction can be achieved using reverse iontophoresis 
together with electroporation (see Figure 3). A possible 
explanation for the phenomenon observed in Figure 3 is that 
electroporation can create nanochannels within the skin,23,24 
and these nanochannels provide a low travelling resistance 
pathway for urea to pass through. Researchers have shown 
that a low and long-lasting voltage pulse (#5 kV/cm, about 
500 µsec) can produce pores with diameters of 10–50 µm23 
and even up to 600 µm.24 The higher the electrical field 
strength of the electroporation used, the more/larger the 
nanochannels that are created, resulting in increased trans-
dermal urea extraction. The findings shown in Figure 6 agree 
with this hypothesis. After application of electroporation to 
the skin, a reduction in post-experimental skin impedance is 
observed, and this may be due to formation of nanochannels. 
The resulting drop in skin impedance is effectively propor-
tional to the electrical exposure dose (voltage × total pulse 
duration).25 As shown in Figure 6, the increased electrical 
field strength of electroporation causes further reduction in 
post-experimental skin impedance, and this may be due to 
more/larger nanochannels being formed.
PSA is a negatively charged large molecule with a 
molecular weight of about 34 kDa. Because PSA is a 
large molecule, it is expected that PSA extraction by 
reverse iontophoresis is facilitated by electro-osmosis 
but not by electromigration. It is well known that reverse 
iontophoresis extraction efficiency facilitated by electro-
osmosis is much lower than that by electromigration. Hence, 
as expected, reverse iontophoresis alone cannot facilitate 
PSA transdermal extraction (see Figure 4) because of its 
large molecular size. This is because transdermal extraction 
enhanced by reverse iontophoresis is limited to molecules 
having a molecular weight of 20 kDa or less, because the 
main permeable pathway created by reverse iontophoresis 
is for the skin appendages, such as hair follicles and sweat 
glands.16 As shown in Figure 4, electroporation alone with 
a high electrical field strength of 296 V/cm was found 
to be able to induce extremely small PSA transdermal 
extraction. This shows that electroporation at 296 V/cm 
can help to create nanochannels within the skin,23,24 which 
are just large enough (perhaps about 34 kDa) for passage 
of PSA molecules. On the other hand, slightly more PSA 
transdermal extraction can be achieved by electroporation 
at 592 V/cm alone as compared with electroporation at 
296 V/cm alone. This shows that electroporation at 592 V/cm 
is able to create more/larger nanochannels as compared 
with electroporation at 296 V/cm. It is well known that the 
combination of electroporation and reverse iontophoresis has 
additional benefits on molecule extraction across the skin. 
It was observed that electroporation at 296 or 592 V/cm 
together with application of reverse iontophoresis facilitates 
A
BD
C
Figure 8 Pictures of the skin surface before and after each extraction experiment. All pictures were captured by a microscope with a magnification of 60×. (A and B) Before 
and after the extraction experiment, respectively, with application of electroporation (74 V/cm) and reverse iontophoresis (phase duration = 180 seconds). (C and D) Before 
and after extraction experiment, respectively, with application of electroporation (592 V/cm) and reverse iontophoresis (phase duration = 180 seconds).
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considerable PSA   extraction. A possible explanation for the 
phenomenon observed in Figure 4 is that electroporation 
with higher electrical field strength can cause more/larger 
nanochannels to be created, and this causes the increase in 
transdermal PSA extraction. Again, the finding shown in 
Figure 6 agrees with this hypothesis and the explanation 
is the same as described above. On the other hand, it was 
observed that electroporation with a higher electrical field 
strength can enhance skin permeability of molecules with 
a molecular weight of 34 kDa. Our finding is in agreement 
with those reported by other researchers, who suggest that 
electroporation can increase skin permeability of molecules 
with a molecular weight of at least 40 kDa.18,19 Osteopontin 
is a large molecule carrying a negative charge. It has a 
molecular weight of about 33 kDa. Given that osteopontin 
has a large molecular size, it is expected that osteopontin 
extraction by reverse iontophoresis is enhanced by electro-
osmosis rather than electromigration. Reverse iontophoresis 
extraction efficiency facilitated by electro-osmosis is much 
lower than that by electromigration. Therefore, owing to its 
large molecular size and low extraction efficiency, reverse 
iontophoresis alone cannot facilitate transdermal osteopontin 
extraction (see Figure 4) and this is within our expectations. 
Again, it was observed that electroporation alone with a 
high electrical field strength (592 V/cm) could induce small 
transdermal osteopontin extraction. With the aid of reverse 
iontophoresis, electroporation at 296 or 592 V/cm was also 
found to facilitate considerable osteopontin extraction. The 
explanation is the same as described above.
Based on the findings shown in Figures 3–5, it is   possible 
to have simultaneous transdermal extraction of urea, PSA, 
and osteopontin by reverse iontophoresis together with 
  electroporation, provided that electroporation has a high 
electrical field strength of at least 296 V/cm.
Self-normalization concept has been employed in the 
test parameter of Zbefore/Zafter in order to avoid the large 
pig-to-pig differences in skin. Zbefore/Zafter can eliminate 
the effect of pig-to-pig variation during data analysis and 
therefore allows the skin impedance to be studied without the 
nonuniformities introduced by pig-to-pig variation. For the 
test parameter of Zbefore/Zafter, if its value is greater than 1, it 
means that the post-experimental skin impedance is smaller 
than the pre-experimental skin impedance. As shown in 
Figure 6, it was found that all the values of Zbefore/Zafter are 
greater than 1. This means that the value of skin impedance 
decreases after the application of reverse iontophoresis, 
electroporation, or a combination of the two techniques. 
During reverse iontophoresis, skin may be polarized, and ion 
(eg, H+ and OH-) accumulation occurs inside the skin and this 
may be the reason for the reduction of skin impedance after 
application of reverse iontophoresis. During electroporation, 
nanochannels are formed on the skin.23,24 Therefore, the 
resistance of the skin barrier for the impedance current to flow 
decreases, and the impedance value decreases consequently. 
As shown in Figure 6, the increase of electric field strength 
of the electroporation results in more reduction of the post-
experimental skin impedance. A possible explanation for this 
phenomenon is that more/larger nanochannels are formed 
if electroporation with a higher electrical field strength 
is used. Our results agree with those of others showing 
that the resulting drop in skin impedance is effectively 
proportional to the electrical exposure dose (voltage × total 
pulse duration).25
As shown in Figure 7, although no significant changes 
were observed in the values of Zbefore/Zafter with time after appli-
cation of electroporation (electric field strength = 592 V/cm; 
pulse width = 1 msec; number of pulses per   second = 10) 
and reverse iontophoresis (symmetrical biphasic dc;   current 
density = 0.3 mA/cm2; phase   duration = 180   seconds), an 
extremely small decrease in the value of Zbefore/Zafter was 
detected with time. This meant that post-experimental skin 
impedance gradually increased with time. The increase in 
post-experimental skin impedance may be due to recovery 
of the skin, leading to reduction of the amount and size of 
the nanopore.
Finally, although PSA and osteopontin can be transder-
mally extracted, electroporation with a high electrical field 
strength of at least 296 V/cm should be used. Therefore, it 
is not clinically feasible for safety reasons and induction of 
pain sensation and involuntary muscle contractions.
Conclusion
A new method for noninvasive transdermal extraction of 
PSA and osteopontin by reverse iontophoresis together with 
electroporation has been demonstrated. Reverse iontophore-
sis alone cannot facilitate transdermal extraction of PSA and 
osteopontin, while application of electroporation has a further 
enhancement effect on molecule extraction. The higher the 
electrical field strength of electroporation, the higher the 
enhancement effect on molecule extraction. Finally, it is 
possible to have simultaneous transdermal extraction of urea, 
PSA, and osteopontin by reverse iontophoresis together with 
electroporation, on the condition that electroporation has a 
high electrical field strength of at least 296 V/cm. However, 
because of the need for electroporation with a high electrical 
field strength, this method is not clinically feasible.
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